| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |